Search and analyze individual stocks with comprehensive metrics

Alembic Ltd

ALEMBICLTDResidential, Commercial Projects
95.16+0.00 (+0.00%)
As on 19 Jan 2026, 10:09 amMarket Open

Fundamental Score

...

Alembic Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

13.69%
Poor

Return on Capital Employed

6.90%
Excellent

Operating Profit Margin (5Y)

32.80%
Good

Dividend Yield

2.39%

Valuation Metrics

Excellent

Price to Earnings

7.95x

Market Capitalization

2.57K (Cr)

Industry P/E

35.86x

Growth Metrics

Poor

YoY Quarterly Profit Growth

6.17%
Poor

YoY Quarterly Sales Growth

5.58%
Excellent

Sales Growth (5Y)

24.58%
Poor

EPS Growth (5Y)

-1.12%
Poor

Profit Growth (5Y)

-1.12%

Financial Health

Excellent

Debt to Equity

0.00x
Excellent

Interest Coverage

65.59x
Poor

Free Cash Flow (5Y)

-84.37 (Cr)

Ownership Structure

Good

Promoter Holding

70.88%
Poor

FII Holding

1.38%
Poor

DII Holding

0.05%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
70.88%
Promoter Holding
2.57K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of ALEMBICLTD across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Operating Margins (32.80%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 7.95 vs Industry: 35.86)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Consistent Growth Track Record (24.58% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (65.59x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (70.88%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

5 factors identified

Suboptimal ROCE (6.90%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Weak Earnings Growth (-1.12% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.

Stagnant Profit Growth (-1.12% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.

Negative Free Cash Flow (₹-84.37 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 1.43%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

Loading Peer Comparison

Finding companies in the Residential, Commercial Projects sector...

Financial Statements

Comprehensive financial data for Alembic Ltd

About ALEMBICLTD

Business Overview

Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, entrepreneurs, corporates, business houses, HNIs, NRIs, and pharmaceutical companies. The company was incorporated in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.

Company Details

Symbol:ALEMBICLTD
Industry:Residential, Commercial Projects
Sector:Residential, Commercial Projects

Key Leadership

Ms. Malika Chirayu Amin
MD, CEO & Executive Director
Mr. Udit C. Amin
MD & Director
Mr. Rasesh Shah
Chief Financial Officer

Corporate Events

Recent
Ex-Dividend Date
2025-08-05

ALEMBICLTD Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)13.69%
Return on Capital Employed6.90%
Operating Profit Margin (5Y)32.80%
Debt to Equity Ratio0.00
Interest Coverage Ratio65.59

Growth & Valuation

Sales Growth (5Y)24.58%
Profit Growth (5Y)-1.12%
EPS Growth (5Y)-1.12%
YoY Quarterly Profit Growth6.17%
YoY Quarterly Sales Growth5.58%

Frequently Asked Questions

What is the current price of Alembic Ltd (ALEMBICLTD)?

As of 19 Jan 2026, 10:09 am IST, Alembic Ltd (ALEMBICLTD) is currently trading at ₹95.16. The stock has a market capitalization of ₹2.57K (Cr).

Is ALEMBICLTD share price Overvalued or Undervalued?

ALEMBICLTD is currently trading at a P/E ratio of 7.95x, compared to the industry average of 35.86x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Alembic Ltd share price?

Key factors influencing ALEMBICLTD's price include its quarterly earnings growth (Sales Growth: 5.58%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Alembic Ltd a good stock for long-term investment?

Alembic Ltd shows a 5-year Profit Growth of -1.12% and an ROE of 13.69%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Alembic Ltd compare with its industry peers?

Alembic Ltd competes with major peers in the Residential, Commercial Projects. Investors should compare ALEMBICLTD's P/E of 7.95x and ROE of 13.69% against the industry averages to determine its competitive standing.

What is the P/E ratio of ALEMBICLTD and what does it mean?

ALEMBICLTD has a P/E ratio of 7.95x compared to the industry average of 35.86x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹8 for every ₹1 of annual earnings.

How is ALEMBICLTD performing according to Bull Run's analysis?

ALEMBICLTD has a Bull Run fundamental score of 49/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does ALEMBICLTD belong to?

ALEMBICLTD operates in the Residential, Commercial Projects industry. This classification helps understand the competitive landscape and sector-specific trends affecting Alembic Ltd.

What is Return on Equity (ROE) and why is it important for ALEMBICLTD?

ALEMBICLTD has an ROE of 13.69%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Alembic Ltd generates profits from shareholders' equity.

How is ALEMBICLTD's debt-to-equity ratio and what does it indicate?

ALEMBICLTD has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is ALEMBICLTD's dividend yield and is it a good dividend stock?

ALEMBICLTD offers a dividend yield of 2.39%, which means you receive ₹2.39 annual dividend for every ₹100 invested.

How has ALEMBICLTD grown over the past 5 years?

ALEMBICLTD has achieved 5-year growth rates of: Sales Growth 24.58%, Profit Growth -1.12%, and EPS Growth -1.12%.

What is the promoter holding in ALEMBICLTD and why does it matter?

Promoters hold 70.88% of ALEMBICLTD shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is ALEMBICLTD's market capitalization category?

ALEMBICLTD has a market capitalization of ₹2575 crores, placing it in the Small-cap category.

How volatile is ALEMBICLTD stock?

ALEMBICLTD has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for ALEMBICLTD?

ALEMBICLTD has a 52-week high of ₹N/A and low of ₹N/A.

What is ALEMBICLTD's operating profit margin trend?

ALEMBICLTD has a 5-year average Operating Profit Margin (OPM) of 32.80%, indicating the company's operational efficiency.

How is ALEMBICLTD's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 5.58% and YoY Profit Growth of 6.17%.

What is the institutional holding pattern in ALEMBICLTD?

ALEMBICLTD has FII holding of 1.38% and DII holding of 0.05%. Significant institutional holding often suggests professional confidence in the stock.